Company / PP&E (Net)
Traws Pharma, Inc. PP&E (Net) History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$7.0K
FY2024
5-year range
$7.0K / $52.0K
FY2020-FY2024
Trend
-68.2%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
PP&E (Net) has declined for 4 consecutive years, from $52,000 in FY2020 to $7,000 in FY2024.
Based on SEC 10-K filings.
$7,000 in FY2024 with a 5-year CAGR of -32.5%.
Declined from $24,000 to $7,000 over the past 2 years.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -43.1%
- 5-Year CAGR
- -32.5%
- 10-Year CAGR
- -
Key checks
Key Insights
- Traws Pharma, Inc.'s pp&e (net) has declined for 4 consecutive years.
- 5-year CAGR of -32.5%, indicating a declining trend.
- In FY2024, pp&e (net) decreased 68.2% year-over-year.
- Peak pp&e (net) was recorded in FY2015.
Company context
Key Data Points
- Altman Z-Score -42.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $7.0K | -68.2% |
| FY2023 | $22.0K | -8.3% |
| FY2022 | $24.0K | -36.8% |
| FY2021 | $38.0K | -26.9% |
| FY2020 | $52.0K | +4.0% |
| FY2019 | $50.0K | +455.6% |
| FY2018 | $9.0K | -85.9% |
| FY2017 | $64.0K | -57.9% |
| FY2016 | $152.0K | -38.7% |
| FY2015 | $248.0K | -41.0% |
As of FY2024 · SEC 10-K · Updated Jun 28, 2026